JP2016516672A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516672A5
JP2016516672A5 JP2015560373A JP2015560373A JP2016516672A5 JP 2016516672 A5 JP2016516672 A5 JP 2016516672A5 JP 2015560373 A JP2015560373 A JP 2015560373A JP 2015560373 A JP2015560373 A JP 2015560373A JP 2016516672 A5 JP2016516672 A5 JP 2016516672A5
Authority
JP
Japan
Prior art keywords
subject
item
stem cells
items
peripheral blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015560373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/019596 external-priority patent/WO2014134539A1/en
Publication of JP2016516672A publication Critical patent/JP2016516672A/ja
Publication of JP2016516672A5 publication Critical patent/JP2016516672A5/ja
Withdrawn legal-status Critical Current

Links

JP2015560373A 2013-02-28 2014-02-28 幹細胞を動員するための方法および組成物 Withdrawn JP2016516672A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361770533P 2013-02-28 2013-02-28
US61/770,533 2013-02-28
US201361828568P 2013-05-29 2013-05-29
US61/828,568 2013-05-29
US201361904768P 2013-11-15 2013-11-15
US61/904,768 2013-11-15
PCT/US2014/019596 WO2014134539A1 (en) 2013-02-28 2014-02-28 Methods and compositions for mobilizing stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020018528A Division JP2020073589A (ja) 2013-02-28 2020-02-06 幹細胞を動員するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2016516672A JP2016516672A (ja) 2016-06-09
JP2016516672A5 true JP2016516672A5 (enExample) 2017-07-27

Family

ID=51428865

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015560373A Withdrawn JP2016516672A (ja) 2013-02-28 2014-02-28 幹細胞を動員するための方法および組成物
JP2020018528A Withdrawn JP2020073589A (ja) 2013-02-28 2020-02-06 幹細胞を動員するための方法および組成物
JP2021113763A Withdrawn JP2021165306A (ja) 2013-02-28 2021-07-08 幹細胞を動員するための方法および組成物
JP2023015363A Pending JP2023041917A (ja) 2013-02-28 2023-02-03 幹細胞を動員するための方法および組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020018528A Withdrawn JP2020073589A (ja) 2013-02-28 2020-02-06 幹細胞を動員するための方法および組成物
JP2021113763A Withdrawn JP2021165306A (ja) 2013-02-28 2021-07-08 幹細胞を動員するための方法および組成物
JP2023015363A Pending JP2023041917A (ja) 2013-02-28 2023-02-03 幹細胞を動員するための方法および組成物

Country Status (9)

Country Link
US (2) US11116819B2 (enExample)
EP (2) EP2961828A4 (enExample)
JP (4) JP2016516672A (enExample)
KR (3) KR102503695B1 (enExample)
CN (2) CN105431521A (enExample)
AU (3) AU2014224042B2 (enExample)
CA (1) CA2908227A1 (enExample)
SG (2) SG11201508027PA (enExample)
WO (1) WO2014134539A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104411316B (zh) 2012-05-09 2018-05-01 坎泰克斯制药股份有限公司 骨髓抑制的治疗
KR102503695B1 (ko) 2013-02-28 2023-02-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 줄기세포를 동원하기 위한 방법 및 조성물
WO2015171852A2 (en) * 2014-05-08 2015-11-12 The Board Of Regents Of The University Of Texas System Methods and compositions for non-cytotoxic stem cell transplantation
US20160243168A1 (en) * 2015-02-17 2016-08-25 Cantex Pharmaceuticals, Inc. Adoptive cell transfer methods
US10052346B2 (en) 2015-02-17 2018-08-21 Cantex Pharmaceuticals, Inc. Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids
HK1256681A1 (zh) 2015-04-06 2019-10-04 President And Fellows Of Harvard College 用於非清髓性预处理的组合物和方法
EP3302710A4 (en) * 2015-06-03 2019-02-20 The University of Queensland MOBILIZERS AND USE THEREOF
EP3419617A4 (en) * 2016-02-26 2019-10-23 President and Fellows of Harvard College HIGH GRADE TRANSPLANTABLE HEMATOPOETIC STEM CELLS
CN109641051A (zh) 2016-06-17 2019-04-16 美真达治疗公司 用于耗尽细胞的组合物和方法
CN106086075B (zh) * 2016-06-23 2019-08-06 福建医科大学 CXCR4RNAi慢病毒载体的构建方法
WO2018071871A1 (en) * 2016-10-13 2018-04-19 President And Fellows Of Harvard College Compositions and methods for non-myeloablative conditioning
EP3571230A4 (en) 2017-01-20 2020-12-16 Magenta Therapeutics, Inc. COMPOSITIONS AND METHODS FOR DELETION OF CD137 + CELLS
WO2018182612A1 (en) * 2017-03-30 2018-10-04 Progenity Inc. Methods and ingestible devices for the regio-specific release of stem cells at the site of gastrointestinal tract disease
CN108728393B (zh) * 2017-04-24 2020-05-26 中国科学院上海营养与健康研究所 Vcam-1＋单核细胞及其衍生细胞在促进造血干细胞归巢的应用
EP3703715A1 (en) * 2017-10-31 2020-09-09 Magenta Therapeutics, Inc. Compositions and methods for hematopoietic stem and progenitor cell transplant therapy
US20190314407A1 (en) * 2017-10-31 2019-10-17 Magenta Therapeutics Inc. Compositions and methods for the expansion of hematopoietic stem and progenitor cells
CN107711615B (zh) * 2017-10-31 2020-08-11 金华职业技术学院 一种采用浸泡鱼卵获得不育鱼的方法
AU2018358012A1 (en) * 2017-11-03 2020-04-02 Roemer & Heigl Gmbh Extraction of stem cells from bone marrow niches
CN119857155A (zh) 2017-11-29 2025-04-22 海德堡医药研究有限责任公司 用于耗尽cd5+细胞的组合物和方法
US10058573B1 (en) * 2017-12-06 2018-08-28 Magenta Therapeutics, Inc. Dosing regimens for the mobilization of hematopoietic stem cells
US11260079B2 (en) 2017-12-06 2022-03-01 Magenta Therapeutics, Inc. Dosing regimens for the mobilization of hematopoietic stem and progenitor cells
CN111712262A (zh) * 2017-12-06 2020-09-25 美真达治疗公司 用于动员造血干细胞和祖细胞的给药方案
WO2019113456A1 (en) * 2017-12-08 2019-06-13 The Medical College Of Wisconsin, Inc. Chemokine variants as immune stimulants
US20200338132A1 (en) * 2018-01-03 2020-10-29 Magenta Therapeutics Inc. Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disorders
EP3773637A4 (en) * 2018-04-13 2021-12-15 The Regents of The University of California METHOD OF TREATMENT OF SICKLE CELL DISEASE
WO2020047236A1 (en) * 2018-08-30 2020-03-05 The Regents Of The University Of California Mobilization and collection of peripheral blood hematopoietic stem cells from deceased donors
US11495028B2 (en) * 2018-09-28 2022-11-08 Intel Corporation Obstacle analyzer, vehicle control system, and methods thereof
KR102142956B1 (ko) * 2018-11-09 2020-08-10 코아스템(주) 중간엽줄기세포의 증식 및 이동 능력 예측용 바이오마커 및 이의 용도
CN109731002B (zh) * 2019-03-21 2020-02-11 广州沙艾生物科技有限公司 白酒草皂苷r用于制备造血干细胞动员剂的应用
EP4051298A1 (en) * 2019-11-01 2022-09-07 Magenta Therapeutics, Inc. Dosing regimens for the mobilization of hematopoietic stem and progentor cells
KR20220128367A (ko) * 2019-12-31 2022-09-20 엘릭서젠 쎄라퓨틱스, 인크. Zscan4 핵산 및 단백질의 세포 및 조직으로의 온도-기반 일시적 전달
MX2022007905A (es) 2019-12-31 2022-08-25 Elixirgen Therapeutics Inc Administracion transitoria basada en temperatura de acidos nucleicos y proteinas a celulas y tejidos.
US12188049B2 (en) 2020-04-14 2025-01-07 Tzu Chi University Methods for mobilizing stem cells
KR102398968B1 (ko) * 2020-07-13 2022-05-17 (주) 엘피스셀테라퓨틱스 조혈 줄기세포의 가동을 위한 물질-p의 배합 요법
CO2020015994A1 (es) 2020-12-18 2022-06-21 Inst Distrital De Ciencia Biotecnologia E Innovacion En Salud Idcbis Método in vitro para evaluación funcional de progenitores hematopoyéticos
CN116024172B (zh) * 2021-10-27 2025-06-03 复旦大学 一种阳离子化合物在制备造血干细胞或祖细胞动员剂中的应用
AU2022400940A1 (en) * 2021-11-30 2024-06-13 Ohio State Innovation Foundation Engineered cells and uses thereof
EP4463135A2 (en) 2022-01-10 2024-11-20 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
WO2024081820A1 (en) 2022-10-13 2024-04-18 Sana Biotechnology, Inc. Viral particles targeting hematopoietic stem cells
WO2024119157A1 (en) 2022-12-02 2024-06-06 Sana Biotechnology, Inc. Lipid particles with cofusogens and methods of producing and using the same
EP4716750A1 (en) 2023-05-23 2026-04-01 Sana Biotechnology, Inc. Tandem fusogens and related lipid particles
CN116920069B (zh) * 2023-07-06 2024-05-17 廊坊康宝汇泰生物技术有限公司 一种中药提取液及其在促进脐带干细胞分泌vegf中的应用
JPWO2025170079A1 (enExample) * 2024-02-09 2025-08-14
WO2025184529A1 (en) 2024-03-01 2025-09-04 Sana Biotechnology, Inc. Viral particles with fusogen display and related compositions and methods

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07118160B2 (ja) 1983-06-18 1995-12-18 ソニー株式会社 ディジタル情報信号の記録方法
DE3422518A1 (de) 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US6753463B1 (en) 1987-11-18 2004-06-22 Mycogen Corporation Transformed cotton plants
DE3744119A1 (de) 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
US5596090A (en) 1992-07-24 1997-01-21 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human VCAM-1 RNA
ES2210255T3 (es) 1993-06-08 2004-07-01 Smithkline Beecham Corporation Metodos para mejorar la actividad biologica de quimiocinas.
US6042821A (en) 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
DE19549232C2 (de) 1995-12-20 1998-05-20 Boehringer Mannheim Gmbh Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern
CN1275596C (zh) 1997-05-14 2006-09-20 阿特罗吉尼克斯公司 普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用
CA2403823A1 (en) 2000-03-21 2001-09-27 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of vcam-1
WO2005014023A1 (en) 2003-07-29 2005-02-17 Dompe' Pha.R.Ma S.P.A. Pharmaceutical combination of g-csf and plgf useful for blood stem cell
KR100533978B1 (ko) * 2004-06-30 2005-12-07 주식회사 하이닉스반도체 반도체 소자 제조 방법
JP2008509928A (ja) * 2004-08-13 2008-04-03 アノーメド インコーポレイテッド 前駆／幹細胞を動員するためのケモカインの組み合わせ
WO2006067170A1 (en) 2004-12-23 2006-06-29 Laboratoires Serono S.A. G-csf polypeptides and uses thereof
CN101500595A (zh) * 2006-08-07 2009-08-05 健赞股份有限公司 组合治疗
WO2008067115A2 (en) * 2006-11-03 2008-06-05 The Board Of Trustees Of The Leland Stanford Junior University Selective immunodepletion of endogenous stem cell niche for engraftment
US8383124B2 (en) * 2008-03-12 2013-02-26 Children's Hospital Medical Center Mobilization of hematopoietic stem cells
US20110135651A1 (en) 2008-08-19 2011-06-09 Children's Hospital Medical Center Method and composition for enhancing hematopoietic stem cell mobilization
EP2356128A1 (en) * 2008-09-15 2011-08-17 Endotis Pharma Oligosaccharide compounds for use in mobilising stem cells
CN108379292A (zh) 2008-11-06 2018-08-10 印第安纳大学研究与技术公司 增强造血干细胞植入过程的材料和方法
US8642569B2 (en) * 2009-01-21 2014-02-04 The General Hospital Corporation Methods for expansion of hematopoietic stem and progenitor cells
WO2011030847A1 (ja) 2009-09-10 2011-03-17 国立大学法人京都大学 造血幹細胞誘導剤組成物
SG192254A1 (en) * 2011-01-31 2013-08-30 Royal Medical Group Pllc Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
US20120225028A1 (en) 2011-03-02 2012-09-06 Moshe Cohen Compositions and methods for mobilization of stem cells
KR102503695B1 (ko) 2013-02-28 2023-02-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 줄기세포를 동원하기 위한 방법 및 조성물

Similar Documents

Publication Publication Date Title
JP2016516672A5 (enExample)
JP2021165306A (ja) 幹細胞を動員するための方法および組成物
Panch et al. Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy
Suratt et al. Human pulmonary chimerism after hematopoietic stem cell transplantation
Pusic et al. Update on clinical experience with AMD3100, an SDF-1/CXCL12–CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells
Peled et al. The high-affinity CXCR4 antagonist BKT140 is safe and induces a robust mobilization of human CD34+ cells in patients with multiple myeloma
Rocha et al. New approaches for improving engraftment after cord blood transplantation
Goligorsky et al. Dysfunctional endothelial progenitor cells in chronic kidney disease
Sangidorj et al. Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model
Andreone et al. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial
Wang et al. EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation
Hildebrandt et al. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation
Fadini Is bone marrow another target of diabetic complications?
Falkenham et al. Early fibroblast progenitor cell migration to the AngII-exposed myocardium is not CXCL12 or CCL2 dependent as previously thought
Metheny et al. Posttransplant intramuscular injection of PLX-R18 mesenchymal-like adherent stromal cells improves human hematopoietic engraftment in a murine transplant model
Strober Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation
De Vries et al. The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications
Davy et al. Hematopoietic stem cells are a critical sub-population of whole bone marrow in the treatment of myocardial infarction
Cannon Iii et al. BM-derived cell therapies for cardiovascular disease
US20090035318A1 (en) Method and composition for increasing the engraftment efficiency of stem cells
Beksac et al. Leland Metheny1*, Saada Eid2, 3, Karen Lingas2, 3, Racheli Ofir4, Lena Pinzur4, Howard Meyerson5, 6, Hillard M. Lazarus1 and Alex Y. Huang2, 3, 5, 6
Dams-Kozlowska et al. Effects of designer hyper-interleukin 11 (H11) on hematopoiesis in myelosuppressed mice
Greco et al. 253: Diminished Biological Potency of BM-Derived CD133+ Cells Obtained from Patients with Coronary Artery Disease in in vitro and in vivo Studies
Ramirez et al. 252: Mobilization of Murine HSCs with AMD15057, A Small Molecule Inhibitor of CD49d (VLA4)
Olavarria Autografting in Chronic Myeloid Leukemia